Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
出版年份 2022 全文链接
标题
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
作者
关键词
-
出版物
INFLAMMOPHARMACOLOGY
Volume 30, Issue 4, Pages 1167-1178
出版商
Springer Science and Business Media LLC
发表日期
2022-07-07
DOI
10.1007/s10787-022-01020-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Food Effects on the Formulation, Dosing, and Administration of Cannabidiol (CBD) in Humans: A Systematic Review of Clinical Studies
- (2021) Lucy H. Silmore et al. PHARMACOTHERAPY
- Chronic nociplastic pain affecting the musculoskeletal system
- (2021) Eva Kosek et al. PAIN
- Cannabis and Cannabinoids in Reproduction and Fertility: Where We Stand
- (2021) Bruno M. Fonseca et al. Reproductive Sciences
- Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials
- (2021) José María Prieto González et al. Expert Review of Neurotherapeutics
- Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER+ breast cancer cells: Impact on aromatase and steroid receptors
- (2021) Cristina Amaral et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The Effects of Food on Cannabidiol Bioaccessibility
- (2021) Khadijeh Mozaffari et al. MOLECULES
- A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study
- (2021) Luis Vitetta et al. INFLAMMOPHARMACOLOGY
- Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic
- (2021) José Alexandre S. Crippa et al. JAMA Network Open
- Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain
- (2021) Mary-Ann Fitzcharles et al. DRUGS
- Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment
- (2021) Tibor Stark et al. PHARMACOLOGICAL RESEARCH
- Enhancing Endocannabinoid Control of Stress with Cannabidiol
- (2021) Jeremy D. Henson et al. Journal of Clinical Medicine
- Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
- (2020) E. Appiah-Kusi et al. PSYCHOPHARMACOLOGY
- Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
- (2020) Joshua D. Brown Journal of Clinical Medicine
- Medical cannabis in the UK: From principle to practice
- (2020) Anne Katrin Schlag et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome
- (2020) Gil Bar-Sela et al. Cancers
- Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats
- (2020) Martina Di Bartolomeo et al. PHARMACOLOGICAL RESEARCH
- Cannabidiol: pharmacology and therapeutic targets
- (2020) Stevie C. Britch et al. PSYCHOPHARMACOLOGY
- Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies
- (2019) Tarek Taha et al. ONCOLOGIST
- A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment
- (2019) Lesley Taylor et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Qualifying Conditions Of Medical Cannabis License Holders In The United States
- (2019) Kevin F. Boehnke et al. HEALTH AFFAIRS
- Cannabinoid Regulation of Fear and Anxiety: an Update
- (2019) Eleni P. Papagianni et al. Current Psychiatry Reports
- Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry
- (2019) Michael Ueberall et al. Journal of Pain Research
- Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
- (2019) Joshua D. Brown et al. Journal of Clinical Medicine
- Cannabidiol (CBD) use in psychiatric disorders: A systematic review
- (2019) Stefania Bonaccorso et al. NEUROTOXICOLOGY
- Cannabis and Pain
- (2019) Ethan B Russo PAIN MEDICINE
- The endocannabinoid system: Novel targets for treating cancer induced bone pain
- (2019) Jia Sun et al. BIOMEDICINE & PHARMACOTHERAPY
- The Pharmacokinetics and the Pharmacodynamics of Cannabinoids
- (2018) C.J. Lucas et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
- (2018) Manoela V. Fogaça et al. NEUROPHARMACOLOGY
- Potential Mechanisms Underlying Centralized Pain and Emerging Therapeutic Interventions
- (2018) Olivia C. Eller-Smith et al. Frontiers in Cellular Neuroscience
- No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
- (2018) Ila M. P. Linares et al. Frontiers in Pharmacology
- Role of the endocannabinoid system in drug addiction
- (2018) Jorge Manzanares et al. BIOCHEMICAL PHARMACOLOGY
- Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain
- (2018) Danilo De Gregorio et al. PAIN
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
- (2018) Kerri A. Schoedel et al. EPILEPSY & BEHAVIOR
- Cannabidiol regulates the expression of hypothalamus-pituitary-adrenal axis-related genes in response to acute restraint stress
- (2018) Adrián Viudez-Martínez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Cannabis, Cannabinoids, and Sleep: a Review of the Literature
- (2017) Kimberly A. Babson et al. Current Psychiatry Reports
- Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
- (2017) Eva Martínez-Pinilla et al. Frontiers in Pharmacology
- Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
- (2017) Antonio W. Zuardi et al. Frontiers in Pharmacology
- Neurobiology of fibromyalgia and chronic widespread pain
- (2016) Kathleen A. Sluka et al. NEUROSCIENCE
- Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fiber stimulation
- (2016) Fei Yang et al. PAIN
- Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents
- (2016) Pius S. Fasinu et al. PHARMACOTHERAPY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
- (2015) Chandni Hindocha et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neurobiological Interactions Between Stress and the Endocannabinoid System
- (2015) Maria Morena et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- (2015) Esther M. Blessing et al. Neurotherapeutics
- Cannabis and Stroke
- (2015) Daniel G. Hackam STROKE
- Regulatory role of the cannabinoid CB2receptor in stress-induced neuroinflammation in mice
- (2014) S Zoppi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neurotrophins, endocannabinoids and thermo-transient receptor potential: a threesome in pain signalling
- (2014) Isabel Devesa et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons
- (2014) Z.-Y. Wang et al. NEUROSCIENCE
- Adverse Cardiovascular, Cerebrovascular, and Peripheral Vascular Effects of Marijuana Inhalation: What Cardiologists Need to Know
- (2013) Grace Thomas et al. AMERICAN JOURNAL OF CARDIOLOGY
- The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
- (2013) Alline C. Campos et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The Pharmacologic and Clinical Effects of Medical Cannabis
- (2013) Laura M. Borgelt et al. PHARMACOTHERAPY
- Cannabidiol enhances consolidation of explicit fear extinction in humans
- (2013) Ravi K. Das et al. PSYCHOPHARMACOLOGY
- A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray
- (2012) C. G. Stott et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Tolerance to Effects of High-Dose Oral Δ9-Tetrahydrocannabinol and Plasma Cannabinoid Concentrations in Male Daily Cannabis Smokers
- (2012) David A. Gorelick et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- Chronic insomnia
- (2012) Charles M Morin et al. LANCET
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors
- (2011) María S García-Gutiérrez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine
- (2011) Philip Robson Expert Opinion On Drug Safety
- A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
- (2011) W Notcutt et al. Multiple Sclerosis Journal
- Effects of cannabis on cognitive function in patients with multiple sclerosis
- (2011) K. Honarmand et al. NEUROLOGY
- Endocannabinoid signalling: has it got rhythm?
- (2010) Linda K Vaughn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Reduction of Bone Cancer Pain by Activation of Spinal Cannabinoid Receptor 1 and Its Expression in the Superficial Dorsal Horn of the Spinal Cord in a Murine Model of Bone Cancer Pain
- (2009) Shingo Furuse et al. ANESTHESIOLOGY
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
- (2009) Jeremy R. Johnson et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond
- (2008) Roger G. Pertwee ADDICTION BIOLOGY
- Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
- (2008) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
- Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
- (2008) Antonio Waldo Zuardi REVISTA BRASILEIRA DE PSIQUIATRIA
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search